Physician profile
Kevin Bree
NPI 1659735462
$272.43
in general payments reported to CMS, 2019-2025
8 companies · $36.72 in 2025
The $36.72 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.45 · 2020: $32.09 · 2021: $30.37 · 2022: $75.94 · 2024: $83.86 · 2025: $36.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $69.01 | 2022-2024 | Ligasure |
| Merck Sharp & Dohme LLC | $45.86 | 2019-2021 | |
| Ethicon US, LLC | $36.72 | 2025 | Enseal, Echelon Flex, Enseal X1 |
| Mimedx Group, INC. | $36.19 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $27.44 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.75 | 2022 | |
| Avanos Medical | $16.88 | 2020 | |
| Abbvie INC. | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Bree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.